Trial Profile
Clinical Trials Insight: 700051712
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 15 Dec 2009
Price :
$35
*
At a glance
- Drugs Birch pollen allergy immunotherapy (Primary)
- Indications Allergic rhinitis; Hypersensitivity
- Focus Registrational; Therapeutic Use
- Sponsors Stallergenes SA
- 15 Dec 2009 New trial record.